Study of the natural course of essential hyperlipemia discloses that this disease is frequently associated with premature atherosclerosis. It is, therefore, our contention that we can no longer regard essential hyperlipemia as a benign disease. Heparin administered intravenously to patients with essential hyperlipemia produces dramatic though transient lowering of total lipids. This is due predominantly to heparin's effect upon neutral fat. Normal controls show no significant differences in their lipid response to heparin, though of course the degree of these changes is comparatively smaller.
C ONTINUAL observation of the clinical course of essential hyperlipemia prompts us to state that, contrary to previous concepts,' it is no longer tenable to believe that this is a benign disease. The evidence presented below illustrates that premature atherosclerosis is found in essential hyperlipemia, and that when present it is associated with hypercholesterolemia. Essential or idiopathic hyperlipemia is characterized by serum which contains an abnormally large amount of neutral fat and which may therefore, on standing, appear grossly milky. There usually is, but need not necessarily be, elevated serum levels of cholesterol, cholesterol esters, and phospholipids.
Hyperlipemia is called essential when it is found in the absence of diseases which are known to be associated with a secondary hyperlipemia. These diseases are diabetes mellitus, lipid nephrosis, the nephrotic stage of glomerulonephritis, thrombosis of the renal veins, pancreatitis, hepatic disease, obstructive jaundice, poisoning, pregnancy, anemias, anoxemia, Von Gierke's disease, cachexia and Niemann-Pick disease. Myxedema has been considered to be one of the causes of secondary hyperlipemia, but it has been our experience that myxedema is characterized by hypercholesterolemia alone rather than by an From the Laboratories of the Genesee Hospital, Rochester, N. Y. 255 associated elevation of neutral fat. It is Thannhauser's2 contention that the hyperlipemia of essential hyperlipemia is a retention phenomenon rather than a manifestation of increased lipid production or transportation. We studied a group of seven patients with essential hyperlipemia for periods of one to four years with special and periodic examinations for early or occult cardiovascular disease. Serum lipid analyses were made frequently and the effect of heparin as an antilipemic agent and as a therapeutic tool was investigated.
METHOD AND MATERIAL
Seven patients, six men and one woman, were studied for a period of from one to four years. The present ages of the patients ranges from 35 to 61 years with an average age of 46.1 years. Three healthy subjects ages 28 to 43, two men and one woman, were controls. Lipid analyses were done and the methods used were as follows: for cholesterol and cholesterol esters, that of Bloor and Knudson3; for fatty acids, that of Stoddard and Drury4; for lipid phosphorus, that of Youngburg and Young-burg5, using the method of Fiske and SubbaRow.6 The total lipids were determined gravimetrically according to the method of Rubin.7 The Moreton nepholometric method' of measuring chylomicrons was used and the results or turbidity indexes are reported as Moreton units. If the resting electrocardiogram was normal and symptoms were suggestive of angina pectoris, exercise electrocardiograms were (lone according to our modified twostep test method.9"-0 Ballistocardiograms were performed in many instances, using a high-frequency cations the skin temperatures before and after applications of heat to the lower extremities was measured under basal conditions in a special room kept at 66 F. The Rauh surface pyrometer was used. Diets used were not measured but gross reduction of cholesterol and/or fat was used. Glucose tolerance tests were done when indicated. The effect of heparin in essential hyperlipemia was tested by giving intravenous heparin to patients in the fasting state. The amount of heparin was 1 mg. per kilogram, and following this blood specimens were drawn at 1-hour, 2-hour, 3-hour and 24-hour intervals.
RESULTS
The blood chemistry figures (tables 1 and 2) demonstrate that for the period of observation, these patients with essential hyperlipemia showed no drastic change in their serum lipids. Improvement due to dietary restrictions or 257 weight reductions was only transient. This may be because the patients became careless in their eating habits, but it is more likely that a lipid escape phenomenon appeared since it occurred even if the patients were kept consistently at lower weight levels. The exception to this finding was patient G. T. who demonstrated dramatic return of serum levels to normal during combined dietary and heparin therapy (table 1) . However, this individual had had the shortest period of observation, and it will be necessary to recheck these results within the next year before they can be considered more than a transitory phenomenon.
Heparin produced profound effects upon serum lipids in both healthy controls as well as in patients who had essential hyperlipemia (see tables 1, 2, 3 and 4). The maximum 0. FroIG. 1. Effect of heparin upon serum lipids in a patient with essential hyperlipemia. mended the use of the free cholesterol-phospholipid ratio. In tables 2 and 4 these two ratios as well as the cholesterol ester-cholesterol ratios are recorded for all patients and controls before and after heparin. Heparin produced neither marked nor consistent changes in these ratios. There is, in many cases, some indication of improvement in the cholesterol-phospholipid ratios, but it is unlikely that this is significant. A review of the fasting lipid ratios discloses no new concepts.
These ratios often demonstrate what is felt to be a prognostically "bad" ratio, that is a high numerical ratio, but premature cardiovascular pathology is found in the presence of a "good" ratio, as for example in patient G. T. (table 2) 
DISCUSSION
The serum hypercholesterolemia so frequently found in essential hyperlipemia is considered to be due neither to increased production nor to increased utilization or transportation of fat depots.2 The hypercholesterolemia FIG. 7 . Skin temperatures of the right foot following immersion of the arms in hot water (43 C.) in patient E. I. Each line represents one toe, the dotted lines on 3/23/50 and the solid lines on 10/17/50. The arrow points to the time interval on 3/23/50 when the right big toe showed a bluish discoloration. Such discoloration did not occur on 10/17/50. may be entirely secondary to the greater carrying capacity of the elevated level of serum neutral fat. Whatever the mechanism of this hypercholesterolemia is, it is our fervent belief that these patients must be watched for signs of premature atherosclerosis. Four of the seven patients described in this manuscript manifested both signs or symptoms of premature atherosclerotic involvement of the coronary or peripheral vascular tree (table 5) . Serum lipid studies in these subjects possess, therefore, an urgent clinical appeal.
That essential hyperlipemia may be hereditary has been commented upon before. Our data give further credence to this concept, for the sister of patient L. W. demonstrates the same abnormal pattern of serum lipids that he shows (tables 1 and 6). The blood serum values of the mother of patient G. T. are distinctly those of hyperlipemia (table 6) it is instructive to note that the serum lipid pattern of the father of G. T. is entirely normal. The mother's hyperlipemia may, however, be secondary rather than essential because unlike all other subjects in this series (by definition) she has diabetes mellitus. Another comparable mother-male child relationship was discovered (patient L. W.), and we have begun further investigation of pos- Intravenous heparin produced profound changes in the sera of our patients, but we feel that it is impossible at this time to state that heparin should be considered to be a therapeutic agent in essential hyperlipemia.
Eventually we must answer the question, what happens to the lipids in the sera that heparin clears? The Danish investigators'4 suggest that sulfur-containing compounds such as heparin predispose to a release or precipitation of lipids in blood vessel walls. The spectacular lipid response of patient G. T. to weekly and biweekly therapeutic injections of heparin cannot be denied, but the role of weight reduction which occurred concomitantly in this patient must be evaluated before the role of heparin can be decided upon. half years. Four of these subjects manifested objective and subjective evidence of premature atherosclerosis. Repeated serum lipid analyses in these patients and in normal controls after specific dietary or total caloric restrictions revealed a relatively static blood picture when viewed in terms of years rather than months.
CONCLUSIONS
Intravenous heparin produced dramatic though transient lowering of total lipids, but this was predominantly due to its action upon neutral fats since cholesterol and phospholipids showed only minimal changes. This characteristic of heparin could be demonstrated repeatedly.
The prolonged use of heparin as a therapeutic agent was studied, and though no certain effect can be attributed to this therapy, further study in this direction is warranted.
The turbidity index described in Moreton units is a means of determining quantitatively the changes in chylomicrons, but the biochemical determination of serum neutral fat permits the observation of the same trends.
A dispersing property of heparin could produce the changes in the ultracentrifugal and chylomicron values but there is no explanation at this time for the absolute decrease in neutral fat following heparin administration.
Heparin produced no consistent effect upon the cholesterol-phospholipid, free cholesterolphospholipid or cholesterol esters-cholesterol ratios.
Our control subjects showed no significant differences in their lipid responses to heparin, though of course the degree of these changes was comparatively smaller.
SUMARIO ESPAEiOL
Siete pacientes con hiperlipemia esencial, con un promedio de edad de 46 afios, fueron observados por un promedio de dos aftos y medio. Cuatro de estos sujetos manifestaron evidencia objetiva y subjetiva de ateroesclerosis prematura. Repetidos analisis del suero para lipidos en estos pacientes y en controles normales luego de restricciones especificas en cuanto a la dieta y total de calorfas, revelaron un cuadro relativamente estatico cuando se visualiz6 en t6rmino de afios en lugar de meses.
La heparina intravenosa produjo un decremento dramgtico transiente en el total de lipidos, pero esto fu6 predominantemente debido a la accidn en la grasas neutrales porqu6 el colesterol y las fosfolipinas mostraron solamente cambios minimos. Esta caracteristica de la heparina se pudo demostrar repetidamente.
El uso prolongado de heparina como un agente terapetitico se estudio y aunque ningvin efecto cierto puede ser atribuido a esta terapia, mas investigacion en esta direccidn estA justificada.
El indice de turbieza descrito en unidades Moreton es un medio de determinar cuantitativamente los cambios en quilomicrones, pero la determinacidn bioquimica de la grasa neutral del suero permite la observacidn de las mismas tendencias.
La propiedad de dispersar de la heparina puede producir los cambios en los valores de la ultracentrifuga y quilomicrones pero no existe explicaci6n en el presente para el decremento en grasa neutral que acompafia a la administraci6n de la heparina. La heparina no produjo un efecto consistente en las proporciones de colesterol-fosfolipina, colesterol libre-fosfolipina o esteres de colesterol-colesterol. Nuestros sujetos controles no mostraron diferencias significativas en sus respuestas lipidas a la heparina aunque naturalmente el grado de estos cambios fu6 comparativamente mas pequefio.
